Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity

Molecular Metabolism · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles